THC Therapeutics
THCT · OTC
$0.0003+$0.0001 (+50.00%)TodayMarket closed ·
No price history for this range.
Key indicators
THCT profitability and balance sheet ratios
Return on equity -0.2% in Oct 2018.
| Period | Return on equity |
|---|---|
| Apr 2012 | -0.0% |
| Jul 2012 | -0.8% |
| Oct 2012 | -1.0% |
| Jan 2013 | -1.4% |
| Apr 2013 | -2.0% |
| Jul 2013 | -9.2% |
| Oct 2018 | -0.2% |
Income statement
No financial statements are reported for THC Therapeutics.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Jan 2024 | Apr 2024 | Jul 2024 |
|---|---|---|---|
| Total assets | $0.0M | $0.0M | $0.0M |
| Total liabilities | $3.9M | $3.5M | $3.8M |
| Shareholder equity | −$3.9M | −$3.5M | −$3.8M |
| Cash and short-term investments | $0.0M | $0.0M | $0.0M |
| Total debt | $0.7M | $0.7M | $0.7M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.